Both MNCs, Local Korean Pharmas Under Korean Government Surveillance For IP Protection
This article was originally published in PharmAsia News
SEOUL - In its first examination into intellectual property rights related to deals among pharma companies operating in Korea, South Korea's Fair Trade Commission is now accepting complaints and opinions from 30 leading multinational companies and 18 local Korean companies
You may also be interested in...
SEOUL - In its latest anti-rebate move, South Korea's Fair Trade Commission is offering up to KRW100 million ($82,440) to whistleblowers who uncover illegal rebates offered by pharma companies for sales of their products to hospitals. The new punitive system took effect June 17
SEOUL - OECD has recommended a set of changes - some of them already pursued by the South Korean government - to get South Korea's healthcare system working more efficiently to curtail rapid increases in healthcare spending
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).